Heartflow Sues Rival Over Stolen Trade Secrets

Medical imaging firms face increased legal scrutiny as competitors battle over proprietary technology and personnel poaching.

Updated on Oct. 22, 2026 in Healthcare

Isometric editorial illustration of a clean, minimalist laboratory corridor, symbolizing corporate intellectual property disputes.
Heartflow Inc. has filed a federal lawsuit in Massachusetts against Elucid Bioimaging Inc., alleging patent infringement and misappropriation of trade secrets. AI Illustration. Upload story photo >

Live Poll

Should companies have the right to legally restrict former employees from joining direct competitors?

Heartflow Inc. has initiated a federal lawsuit against competitor Elucid Bioimaging Inc. in Massachusetts, alleging patent infringement and the misappropriation of trade secrets. The complaint centers on claims that Elucid improperly recruited 11 former Heartflow employees to leverage proprietary technical information.

Why it matters

The case highlights the operational risks businesses face when scaling via competitor talent acquisition, particularly when those hires hold deep knowledge of technical designs and business strategy. For operators in specialized tech sectors, these disputes underscore the importance of robust IP protection and restrictive covenants.

The lawsuit involves 11 former Heartflow employees hired by Elucid Bioimaging and centers on 4 specific patents cited in the federal filing. The total impact of the alleged trade secret misappropriation remains subject to ongoing legal determination.

The players

Heartflow Inc.

A developer of non-invasive cardiac imaging technology utilized by clinical practitioners for cardiovascular diagnostic support.

Elucid Bioimaging Inc.

A medical imaging company focused on developing technology to characterize tissue and improve diagnostic accuracy in cardiology.

The details

Heartflow alleges that Elucid Bioimaging utilized its confidential technical designs and business operations data to develop a rival cardiac imaging platform. The suit claims that the 11 former employees possessed critical knowledge of Heartflow's expansion plans and product development, which allegedly served as the basis for the competitor's recent platform growth. The legal filing in the District of Massachusetts seeks to address these claims of patent infringement and improper use of company assets.

Timeline

  1. October 22, 2026: Heartflow filed the complaint against Elucid Bioimaging.

Market Landscape

The story follows the pattern set by the Waymo v. Uber trade secret lawsuit regarding the migration of key personnel between direct market competitors. This dispute highlights the persistent tension between labor mobility and the protection of proprietary technical assets in highly specialized tech sectors.

Operators should review employment agreements and intellectual property policies to ensure robust protection against the migration of technical know-how. Consult with legal counsel to evaluate whether current non-solicitation or confidentiality clauses are enforceable in your specific jurisdiction.

The takeaway

This case serves as a reminder for business owners to audit the onboarding and departure processes for staff with access to sensitive technical data. Monitor the court docket for the District of Massachusetts to observe how the judge handles the claims of misappropriated trade secrets regarding employee mobility.

Further reading

For broader context on current industry developments, visit the Healthcare section.

Source note: This article includes information reported by Bloomberglaw.

Live Poll

Should companies have the right to legally restrict former employees from joining direct competitors?